Application of behavioral therapies in adult and adolescent patients with chronic migraine

Weeks, Randall E.

doi:10.1007/s10072-013-1360-6

Cited by 10 publications

(8 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Psychological factors are well known to influence the development and maintenance of chronic pain 18; 27 , including among youth experiencing chronic headache 19; 23; 52 . In the current study we examined whether self-efficacy, a demonstrated influential cognitive appraisal, may be a protective factor that can mitigate the influence of fear on negative functional outcomes (e.g., disability, depression) as has been observed in adult pain patients 53; 11 .…”

Section: Discussionmentioning

confidence: 99%

The Interplay of Pain-Related Self-Efficacy and Fear on Functional Outcomes Among Youth With Headache

Carpino

Segal

Logan

et al. 2014

The Journal of Pain

View full text Add to dashboard Cite

Pain-related self-efficacy and pain-related fear have been proposed as opposing predictors of pain-related functional outcomes in youth with chronic pain. Self-efficacy is a potential resiliency factor that can mitigate the influence pain-related fear has on outcomes in youth with chronic pain. Drawing from theoretical assertions tested among adults with chronic pain, this study aimed to determine whether pain-related self-efficacy mediates the adverse influence of pain-related fear on functional outcomes in a sample of youth with chronic headache. In a cross-sectional design of 199 youth with headache, self-efficacy was strongly associated with fear, disability, school impairment, and depressive symptoms. Pain intensity and self-efficacy were only modestly related, indicating level of pain has less influence on one’s confidence functioning with pain. Self-efficacy partially mediated relationships between pain-related fear and both functional disability and school functioning but did not mediate the relationship between pain-related fear and depressive symptoms. These results suggest that one’s confidence in the ability to function despite pain and fear avoidance both uniquely contribute to pain-related outcomes in youth with chronic headache. These results further suggest that treatment for chronic headache in youth must focus on not only decreasing pain-related fear but also on enhancing a patient’s pain-related self-efficacy. Perspective Pain-related self-efficacy is an important resiliency factor impacting the influence of pain-related fear on functional disability and school functioning in youth with headache. Enhancing self-efficacy may be a key mechanism for improving behavioral outcomes. Clinicians can reduce pain-related fear and enhance pain-related self-efficacy through interventions that encourage accomplishment and self-confidence.

show abstract

Section: Discussionmentioning

confidence: 99%

The Interplay of Pain-Related Self-Efficacy and Fear on Functional Outcomes Among Youth With Headache

Carpino

Segal

Logan

et al. 2014

The Journal of Pain

View full text Add to dashboard Cite

show abstract

“…Non-pharmacological therapy, in particular behavioral strategies seem to be as effective as pharmacological treatment for headache management ( 3 , 58 , 59 ).…”

Section: The Role Of Metacognition Cognitive Behavioral Therapy (Cbtmentioning

confidence: 99%

Metacognition and Headache: Which Is the Role in Childhood and Adolescence?

et al. 2017

View full text Add to dashboard Cite

Headache, in particular migraine, is one of the most frequent neurological symptoms in children and adolescents and it affects about 60% of children and adolescents all over the world. Headache can affect several areas of child’s functioning, such as school, physical activities, peer, and family relationship. The global and severe burden of this disease requires a multidisciplinary strategy and an effective treatment addressed all of the patient’s needs and based on cutting-edge scientific research. In recent years, research has focused on cognitive factors specifically in functions called metacognitive processes. Metacognition can be defined as the knowledge, beliefs, and cognitive processes involved in monitoring, control, and assessment of cognition. Metacognition seems to be closely related to the ability of theory of mind, the ability to infer, and reason about the mental states of other people in order to predict and explain own behavior. Recent studies found a relationship between metacognitive skills and anxiety, depression, motivation, academic performance, human social interactions, and stress symptoms. This relationship is very interesting for headache treatment, because these factors are the most commonly reported triggers in this disorder and there is a high comorbidity with anxiety and depression in children and adolescents with headache. So, headache and these comorbidities, in particular anxiety and depression, may have in common persistent and maladaptive patterns of thinking which are related to maladaptive metacognitive beliefs. Further research should assess metacognitive processes of children and adolescents with headache in order to increase their ability to control their own cognitive processes and consequently monitor factors which may trigger the attacks.

show abstract

“…Being aware of factors that precipitate or aggravate CM should allow patients to progressively modulate the frequency and duration of their attacks 63. Cognitive-behavioral therapy may also be indicated to assess compliance to preventive medication and to assess modifiable risk factors for CM 62. Other reasons that cause CM patients to seek cognitive-behavioral therapy and other nonpharmacological treatments include poor tolerance and low response to preventive medication, history of overuse of medication, pregnancy, stress, and deficient stress/pain coping strategies 62…”

Section: Management Of Chronic Migrainementioning

confidence: 99%

Tackling chronic migraine: current perspectives

Carod-Artal¹

2014

JPR

View full text Add to dashboard Cite

In the last decade, several diagnostic criteria and definitions have been proposed for chronic migraine (CM). The third edition of the International Classification of Headache Disorders–3 beta, published in 2013, has revised CM diagnostic criteria. CM is defined as “headache occurring on 15 or more days per month for more than 3 months, which has the features of migraine headache on at least 8 days per month.” Patients who meet the criteria for CM and for medication-overuse headache should be given both diagnoses. Worldwide, CM prevalence ranges 1%–3%, and its incidence has been estimated to be 2.5% per year. CM is associated with disability and poor quality of life. Modifiable risk factors include (among others): migraine progression (defined as an increase in frequency and severity of migraine attacks); medication and caffeine overuse; obesity; stressful life events; and snoring. CM patients have a significantly higher frequency of some comorbid conditions, including chronic pain, psychiatric disorders, respiratory illness, and some vascular risk factors. Management includes identification and control of comorbidities and risk factors that predispose to CM; treatment and prevention for medication overuse; early treatment for migraine attacks; and an adequate preventive therapy for CM. Several randomized controlled clinical trials have shown the efficacy of topiramate, amitriptyline, onabotulinumtoxinA, and cognitive-behavioral therapy in CM.

show abstract

Application of behavioral therapies in adult and adolescent patients with chronic migraine

Cited by 10 publications

References 48 publications

The Interplay of Pain-Related Self-Efficacy and Fear on Functional Outcomes Among Youth With Headache

The Interplay of Pain-Related Self-Efficacy and Fear on Functional Outcomes Among Youth With Headache

Metacognition and Headache: Which Is the Role in Childhood and Adolescence?

Tackling chronic migraine: current perspectives

Contact Info

Product

Resources

About